NOS2 and neoplasm: Although TAMs seem to have a low NO production capacity, as is observed in murine mammary and human ovarian tumors, consistent with M2-like and protumor characteristics [44–46], simultaneous ARG1 and inducible nitric oxide synthase (iNOS) pathways have been observed in tumor-licensed TAMs [47].